Search Within

Matthew Galsky

Formats
  1. Journal Article (15)
  2. Meeting Abstract (9)
  3. Book Section (4)
  4. Book Whole (1)
Groups
  1. Department of Medicine (20)
  2. Solid Tumor Oncology Division (20)
  3. Genitourinary Oncology Service (18)
  4. Nursing (8)
  5. Epidemiology and Biostatistics (5)
  6. Surgery (5)

More Groups

People
  1. Dean Bajorin (9)
  2. Howard Scher (8)
  3. William Kelly (8)
  4. Joseph Scattergood (5)
  5. Mary Boyle (5)
  6. Svetlana Mironov (5)

More People

Years
  1. 2021 (1)
  2. 2016 (1)
  3. 2008 (1)
  4. 2007 (5)
  5. 2006 (6)
  6. 2005 (10)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Cancer (3)
  3. Urology (2)
  4. Annals of Oncology (1)
  5. Clinical Cancer Research (1)
  6. Comprehensive Textbook of Genitourinary Oncology. 3rd ed (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Elsevier Inc. (3)
  3. Wiley Blackwell (3)
  4. Elsevier Science, Inc. (2)
  5. Oxford University Press (2)
  6. Springer Verlag (2)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Health-related quality of life (HRQoL) with adjuvant nivolumab (NIVO) vs placebo (PBO) after radical resection for high-risk muscle-invasive urothelial carcinoma (MIUC): Results from the phase 3 CheckMate 274 trialep138
    Meeting Abstract

    Gschwend, J. E.; Bajorin, D.; Galsky, M.; Broughton, E.; Braverman, J.; Koon, H.; Maira-Arce, M.; Hamilton, M.; Shi, L.; Guo, S.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
    Journal Article

    Milowsky, M. I.; Galsky, M. D.; Morris, M. J.; Crona, D. J.; George, D. J.; Dreicer, R.; Tse, K.; Petruck, J.; Webb, I. J.; Bander, N. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2016)

    Fulltext@MSK | Save
  • Management of metastatic bladder cancer
    Book Section

    Galsky, M. D.; Bajorin, D. F.
    In Nargund, V. H.; Raghavan, D.; Sandler, H. M. (Eds.) Urological Oncology. 1st ed (2008)

    Fulltext@MSK | Save
  • Bladder cancer
    Book Section

    Galsky, M. D.; Bajorin, D. F.
    In Schrier, R. W. (Eds.) Diseases of the Kidney and Urinary Tract. 8th ed (2007)

    Fulltext@MSK | Save
  • Chemotherapy for bladder cancer
    Book Section

    Galsky, M. D.; Bajorin, D. F.
    In Waxman, J. (Eds.) Urological Cancers in Clinical Practice (2007)

    Fulltext@MSK | Save
  • Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma
    Journal Article

    Galsky, M. D.; Mironov, S.; Iasonos, A.; Scattergood, J.; Boyle, M. G.; Bajorin, D. F.
    Investigational New Drugs (2007)

    Fulltext@MSK | Save
  • Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function
    Journal Article

    Galsky, M. D.; Iasonos, A.; Mironov, S.; Scattergood, J.; Boyle, M. G.; Bajorin, D. F.
    Cancer (2007)

    Fulltext@MSK | Save
  • Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract
    Journal Article

    Galsky, M. D.; Iasonos, A.; Mironov, S.; Scattergood, J.; Donat, S. M.; Bochner, B. H.; Herr, H. W.; Russo, P.; Boyle, M. G.; Bajorin, D. F.
    Urology (2007)

    Fulltext@MSK | Save
  • Chemotherapy for metastatic bladder, alone or in combination with other treatment
    Book Section

    Galsky, M. D.; Bajorin, D. F.
    In Vogelzang, N. J.; Scardino, P. T.; Shipley, W. U.; Debruyne, F. M. J.; Linehan, W. M. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 3rd ed (2006)

    Fulltext@MSK | Save
  • Phase I study of the effects of renal impairment on the pharmacokinetic (PK) and safety of satraplatin in patients (Pts) with refractory non-hematologic cancer
    Meeting Abstract

    Hong, D. S.; Galsky, M.; Chiorean, E.; Mulkerian, D.; Greene, D.; Nathan, F. E.; Petrone, M.; Camacho, L. H.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save